Giovanna Schioppacassi

This inventor holds 5 USPTO granted patents. Top assignees: Zambon Group, Isagro S.p.a., Isagro S.p.a. and Zambon Group S.p.a.. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giovanna Schioppacassi. Retrieved from https://idiyas.com/inventor/giovanna-schioppacassi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 80.0

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)

Location History:

Rho, IT (1999 - 2000)
Milan, IT (1998 - 2003)

Company Filing History:

Isagro S.p.a. and Zambon Group S.p.a.

where one patent can have more than one assignee

Years Active: 1998-2003

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6583120 - Erythromycin derivative with antibiotic activity (2003-06-24),

2. 6214833 - Pyrimidinone-1,3-oxathiolane derivatives with antiviral activity (2001-04-10),

3. 6103909 - Azole compounds endowed with antimycotic activity for human and (2000-08-15),

4. 5869512 - Azole compounds with antimycotic activity for human and veterinary use (1999-02-09),

5. 5847092 - Erythromycin A 9-0 oxime derivatives endowed with antibiotic activity (1998-12-08),

Title: Celebrating the Innovations of Giovanna Schioppacassi

Introduction

Giovanna Schioppacassi is a distinguished inventor based in Milan, Italy, known for her significant contributions to the field of pharmaceutical innovations. With a remarkable portfolio of five patents, she has been instrumental in developing new antibiotic and antiviral compounds that have the potential to improve patient outcomes and address critical health challenges.

Latest Patents

Among her latest inventions is an **erythromycin derivative with antibiotic activity**. This invention details a novel erythromycin derivative and its pharmaceutically acceptable salts, alongside a method for their preparation and pharmaceutical compositions containing them as active ingredients. Her work aims to enhance the efficacy of existing antibiotic treatments.

Another noteworthy patent is related to **pyrimidinone-1,3-oxathiolane derivatives with antiviral activity**. These compounds are characterized by a specific formula, wherein R groups can vary, offering potential as reverse transcriptase inhibitors, making them valuable in the treatment of viral infections.

Career Highlights

Giovanna Schioppacassi has worked with notable organizations throughout her career, including her tenure at **Zambon Group S.p.a.** and **Zambon Group S.a.**. Her time within these institutions has fostered an environment for creativity and innovation, contributing to her success as a leading inventor in the pharmaceutical field.

Collaborations

Throughout her career, Giovanna has collaborated with esteemed colleagues such as **Enrico Albini** and **Franco Pellacini**. These partnerships have been crucial in the research and development of her innovative pharmaceutical products, enhancing the collaborative spirit of scientific inquiry and invention.

Conclusion

In summary, Giovanna Schioppacassi continues to be a formidable figure in the realm of pharmaceutical inventions. Her dedication to exploring new compounds with antibiotic and antiviral properties represents a meaningful stride towards combating infectious diseases. As she advances her research and patent portfolio, her work will undoubtedly leave a lasting impact on the healthcare industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]